<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Acta Endocrinol (Buchar)</journal-id>
<journal-id journal-id-type="iso-abbrev">Acta Endocrinol (Buchar)</journal-id>
<journal-id journal-id-type="publisher-id">aeb</journal-id>
<journal-title-group>
<journal-title>Acta Endocrinologica (Bucharest)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1841-0987</issn>
<issn pub-type="epub">1843-066X</issn>
<publisher>
<publisher-name>Acta Endocrinologica Foundation</publisher-name>
<publisher-loc>Romania</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31149183</article-id>
<article-id pub-id-type="pmc">6516456</article-id>
<article-id pub-id-type="doi">10.4183/aeb.2017.249</article-id>
<article-id pub-id-type="publisher-id">aeb.2017.249</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Notes &amp; Comments</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>PRELIMINARY INSIGHTS IN OXYTOCIN ASSOCIATION WITH THE ONSET OF DIABETIC NEUROPATHY</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kobylinska</surname>
<given-names>L.</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghita</surname>
<given-names>M.A.</given-names>
</name>
<xref ref-type="aff" rid="A3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caruntu</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="A3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="A6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gabreanu</surname>
<given-names>G.</given-names>
</name>
<xref ref-type="aff" rid="A7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tataru</surname>
<given-names>C.P.</given-names>
</name>
<xref ref-type="aff" rid="A4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Badescu</surname>
<given-names>S.V.</given-names>
</name>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geicu</surname>
<given-names>O.</given-names>
</name>
<xref ref-type="aff" rid="A8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neagu</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Constantin</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="A7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dobrescu</surname>
<given-names>I.</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="A5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zagrean</surname>
<given-names>L.</given-names>
</name>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>“Prof. Dr. Al. Obregia” Clinical Psychiatry Hospital - Child and Adolescent Psychiatry Department, “Carol Davila” University of Medicine and Pharmacy - Bucharest, Romania</aff>
<aff id="A2"><label>2</label>Physiology and Fundamental Neuroscience Department - Bucharest, Romania</aff>
<aff id="A3"><label>3</label>Dermatology Research Laboratory - Bucharest, Romania</aff>
<aff id="A4"><label>4</label>Division of Ophthalmology - Bucharest, Romania</aff>
<aff id="A5"><label>5</label>Child and Adolescent Psychiatry Department, Bucharest, Romania</aff>
<aff id="A6"><label>6</label>“Prof. N. Paulescu” National Institute of Diabetes, Nutrition and Metabolic Diseases - Dermatology, Bucharest, Romania</aff>
<aff id="A7"><label>7</label>“Victor Babes” National Institute of Pathology - Immunology Department, Bucharest, Romania</aff>
<aff id="A8"><label>8</label>University of Bucharest, Faculty of Biology - Biochemistry and Molecular Biology Department, Bucharest, Romania</aff>
<author-notes>
<corresp id="cor1">*Correspondence to: Calin Petru Tataru MD, “Carol Davila” University of Medicine and Pharmacy, Division of Ophthalmology, Alexandru Lahovari Square no 1, Bucharest, 010464, Romania, E-mail: <email>calinpetrutataru@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Apr-Jun</season>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>2</issue>
<fpage>249</fpage>
<lpage>253</lpage>
<permissions>
<copyright-statement>©by Acta Endocrinologica Foundation</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Diabetes is one of the most prevalent chronic disorders, associating numerous somatic and behavioral modifications. Oxytocin has been widely studied for its involvement in social behavior and psychiatric disorders.</p>
<p>This pilot study presents a series of 3 patients with type 1 diabetes and diabetic neuropathy in which the values of plasma oxytocin, neurotensin, β-endorphins, α-MSH, substance P and orexin A were measured in comparison to 3 healthy controls with matching ages. </p>
<p>In the diabetic patients group, there was a strong negative correlation between the value of plasma glucose and oxytocin (r=-0.99, p=0.04), respectively neurotensin (r=-0.99, p=0.03). These values did not correlate in the control group.</p>
<p>The results suggest that oxytocin, in conjunction with neurotensin, could be investigated as a potential early detection marker of diabetic neuropathy and, to our knowledge, this is the first report focusing on plasma oxytocin levels in patients with diabetic neuropathy.</p>
</abstract>
<kwd-group>
<kwd>oxytocin</kwd>
<kwd>diabetic neuropathy</kwd>
<kwd>type 1 diabetes</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>